Promoters with cancer cell-specific activity for melanoma gene therapy

V V Pleshkan1, I V Alekseenko, M V Zinovyeva

  • 1Shemyakin and Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences.

Acta Naturae
|June 1, 2012
PubMed

Insights

This review discusses melanoma-specific gene promoters for targeted cancer therapy. These promoters ensure therapeutic genes are only active in melanoma cells, improving treatment efficacy and patient quality of life.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biotechnology

Background:

  • Melanoma is an aggressive cancer with high mortality rates.
  • Current treatments can affect healthy cells, leading to side effects.
  • Targeted gene therapy offers a potential strategy to improve melanoma treatment outcomes.

Purpose of the Study:

  • To review gene promoters specifically activated in melanoma cells.
  • To highlight the potential of these promoters in cancer gene therapy.
  • To discuss the development of universal anticancer drugs using these elements.

Main Methods:

  • Literature review of gene promoters preferentially expressed in melanoma.
  • Analysis of melanoma-specific regulatory elements.
  • Examination of double promoter systems for enhanced gene therapy.

Main Results:

  • Identified gene promoters highly specific to melanoma cells.
  • Demonstrated that these promoters can reduce off-target gene expression in normal tissues.
  • Highlighted the utility of cancer-specific promoters in developing targeted therapies.

Conclusions:

  • Melanoma-specific promoters are crucial for effective and safe cancer gene therapy.
  • These regulatory elements can lead to the development of novel, targeted anticancer drugs.
  • Further research into promoter-driven gene therapy holds significant promise for melanoma treatment.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...